VillageMD's agreement with Athyrium Capital Management and receipt of $80 million in growth financing positions the organization to expand into more markets and further enhance its technology, as reported by ChicagoInno.
“Our partnership with Athyrium represents an important next step in the history of VillageMD,” VillageMD CEO Tim Barry said in a statement. “While we are happy with the growth we have experienced in the last four years and expect continued growth in the future, we are most proud of the clinical and financial results we have been able to achieve with our primary care partners.”
To read the full article from ChicagoInno, click here.
